ScholarWorks@한양대학교

상세 보기

Subcutaneous administration of a novel formulation of CT-P13 (Infliximab biosimilar) is safe and achieved projected therapeutic drug levels: a phase I study in healthy subjects

  • 유대현
제목
Subcutaneous administration of a novel formulation of CT-P13 (Infliximab biosimilar) is safe and achieved projected therapeutic drug levels: a phase I study in healthy subjects
저자
유대현
발행일
2017-10-30
학회명
25th UEG week 2017
개최지
Barcelona, Spain

ScholarWorks@한양대학교

(04763) 서울특별시 성동구 왕십리로 222 Tel. +82-2-2220-1370 +82-2-2220-1366

COPYRIGHT © 한양대학교 All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.

You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.